National Academy of Sciences, Proceedings of the National Academy of Sciences, 39(112), p. 12005-12010, 2015
Full text: Download
Significance We discovered an improved hydroxamic acid-based small-molecule N-hydroxy-4-[(N(2-hydroxyethyl)-2-phenylacetamido)methyl)benzamide)] that selectively inhibits histone deacetylase 6 catalytic activity in vivo and in vitro. This can have important anticancer activity.